SALT SELECTION FOR BASIC DRUGS

被引:253
作者
GOULD, PL [1 ]
机构
[1] PFIZER LTD,CENT RES,DEPT PHARMACEUT RES & DEV,SANDWICH,KENT,ENGLAND
关键词
D O I
10.1016/0378-5173(86)90055-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:201 / 217
页数:17
相关论文
共 24 条
[11]   PREFORMULATION INVESTIGATION .1. RELATION OF SALT FORMS AND BIOLOGICAL-ACTIVITY OF AN EXPERIMENTAL ANTIHYPERTENSIVE [J].
LIN, SL ;
HUEBNER, CF ;
SWARTZ, CJ ;
LACHMAN, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (09) :1418-&
[12]  
MIYAZAKI S, 1981, J PHARM SCI, V70, P594, DOI 10.1002/jps.2600700604
[13]  
MIYAZAKI S, 1980, INT J PHARM, V6, P77
[14]   SOLUTION RATE OF THEOPHYLLINE SALTS AND EFFECTS FROM ORAL ADMINISTRATION [J].
NELSON, E .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (10) :607-614
[15]   WATER-SOLUBLE DERIVATIVES OF 3-OXY-SUBSTITUTED 1,4-BENZODIAZEPINES [J].
NUDELMAN, A ;
MCCAULLY, RJ ;
BELL, SC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (12) :1880-1885
[16]  
PARROT E, 1982, PHARM DOSAGE FORMS T, V2, P178
[17]  
PO ALW, 1984, INT J PHARM, V18, P287
[18]  
SENIOR N, 1973, J SOC COSMET CHEM, V24, P259
[19]  
WALKING D, 1973, DRUG COSMET IND, V112, P39
[20]   XILOBAM - EFFECT OF SALT FORM ON PHARMACEUTICAL PROPERTIES [J].
WALKLING, WD ;
REYNOLDS, BE ;
FEGELY, BJ ;
JANICKI, CA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (05) :809-819